Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - NEVRO CORP | nvro-ex321_6.htm |
| EX-31.2 - EX-31.2 - NEVRO CORP | nvro-ex312_11.htm |
| EX-31.1 - EX-31.1 - NEVRO CORP | nvro-ex311_7.htm |
| EX-21.1 - EX-21.1 - NEVRO CORP | nvro-ex211_9.htm |
| EX-10.21(B) - EX-10.21(B) - NEVRO CORP | nvro-ex1021b_524.htm |
| EX-10.18(G) - EX-10.18(G) - NEVRO CORP | nvro-ex1018g_523.htm |
| EX-4.6 - EX-4.6 - NEVRO CORP | nvro-ex46_607.htm |
| 10-K - 10-K - NEVRO CORP | nvro-10k_20191231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-211864) and Form S-8 (Nos. 333-229778, 333-223159, 333-216206, 333-209816, 333-202857 and 333-200145) of Nevro Corp. of our report dated February 25, 2020 relating to the consolidated financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
San Jose, California
February 25, 2020